Something wakes in your nervous system decades after you last thought about it. The chickenpox you had at age seven — a week of itching and fever, long forgotten — left a tenant behind. Not in your bloodstream or your organs, but threaded into the neurons running alongside your spine, coiled into the ganglia like a sleeping ember. For most people it stays dark forever. For one in three, it catches fire: a searing, one-sided rash called shingles that burns along a single nerve path, sometimes leaving pain that outlasts the rash by months or years.
That is the official story, and it is robustly supported. But the frontier of the science is stranger than the textbook version. Virologists will tell you, in peer-reviewed language, that they do not know what wakes it. Philosophers of biology will tell you the category of "virus" is contested. And the ghost of Louis Pasteur still argues with Antoine Béchamp about whether the germ makes the terrain sick, or the terrain makes the germ dangerous.
This piece takes all of those threads seriously.
What We Think We Know
Varicella-zoster virus (VZV) is classified as an alphaherpesvirus — a DNA virus in the same family as herpes simplex, with a talent, unique among its relatives, for hiding specifically inside neurons. When chickenpox resolves, VZV does not leave the body. It retreats into the dorsal root ganglia — clusters of sensory nerve cells arranged like beads along the length of the spinal cord — and into the trigeminal ganglia at the base of the skull.
There, it enters what virologists call latency: a remarkable suspended state in which nearly all viral activity halts. The virus stops replicating its DNA. It shuts down translation of almost all its roughly seventy genes. It produces no new virus particles. From the host's perspective, it has vanished. From the virus's perspective — if we can anthropomorphise a strip of nucleic acid — it is waiting.
During latent infection in human trigeminal ganglia, VZV gene expression is restricted to just two transcripts: the VZV latency-associated transcript (VLT) and a related gene called ORF63. Everything else is switched off. No viral DNA replication. No progeny particles. The virus exists as a kind of genetic text that the neuron keeps, but does not read aloud.
Researchers have also discovered a fusion transcript — VLT-ORF63 — that appears to function as an ignition switch during reactivation. When reactivation stimuli are applied in lab conditions, VLT-ORF63 expression is induced, and it in turn triggers widespread VZV gene transcription across the viral genome. How the cell "decides" to produce this fusion transcript remains one of the central unsolved problems in herpesvirus biology.
Shingles is what happens when this latency breaks down. The virus shifts from its dormant state back to active, or lytic, replication. New virus particles assemble, travel outward along the nerve axon, and infect skin cells in the dermatome — the patch of skin served by that particular nerve. The result is the characteristic one-sided stripe of blisters, often preceded by days of burning pain, that has been recognised in medical literature for centuries.
The Ignition Problem
Here is the embarrassing scientific truth, stated plainly: after decades of research, virologists do not know what wakes VZV from latency. They know the conditions that correlate with reactivation. They know something about the molecular biology of the transition. But the actual switch — the precise cellular or viral event that tips a neuron from suppressing the virus to allowing it to bloom — remains unknown.
Reviews published as recently as 2025 and 2026 use nearly identical language to papers from 2013: the mechanisms governing the transition from latency to lytic infection remain "incompletely understood," "largely unknown," or simply "unclear." The repetition across a decade is striking. It is not that science has stalled — researchers are developing sophisticated new neuron models to study VZV for the first time in conditions approaching true biological fidelity — but the core question is still open.
What We Know Correlates With Reactivation
The dominant framework is immunological. T-cell immunity — not the antibody response, but the cellular arm — appears to be the main force keeping VZV suppressed. As this immunity declines, with age, illness, or pharmaceutical immunosuppression, the risk of shingles rises sharply. This is why shingles is more common in people over 50, in those undergoing chemotherapy, in people with HIV, and in those on long-term corticosteroids.
The list of known reactivation triggers is broader still:
Immunosenescence: The gradual age-related decline of T-cell function. VZV-specific T-cell responses measurably weaken after fifty.
Psychological stress: Acute and chronic stress suppress cellular immunity through well-documented neuroendocrine pathways — cortisol, catecholamines — creating a window for viral emergence.
Co-infection: Other viral infections, including COVID-19, appear to trigger VZV reactivation by disrupting immune surveillance. Post-COVID shingles case reports surged from 2021 onward.
Epigenetic shifts: Changes in how the virus's own DNA is chemically marked — histone modifications and methylation patterns — appear to govern whether its genes are silenced or expressed. Perturbations to these marks, from inside or outside the cell, may be permissive of reactivation.
Genetic predisposition: Shingles is more common in certain demographic groups and families, suggesting host genetics modulate susceptibility. Specific HLA haplotypes have been implicated, though the picture is incomplete.
What is notable is that most of these triggers are not simply "the virus is old and wants out." They are terrain factors — conditions of the host environment that apparently determine whether the virus remains silent or becomes active. The virus has not changed. The host has.
The Timeline of a Mystery
The Deeper Question: Does the Virus Exist as We Think It Does?
We have covered the mainstream science honestly, including its admissions of ignorance. Now we arrive at the more radical question — one that sounds fringe but has serious philosophical and scientific ancestry.
Is a virus a thing? Or is it a description of what cells do under certain conditions?
The challenge to conventional virology begins with history. In the late 19th century, Louis Pasteur and Antoine Béchamp argued about the nature of disease — not as a personal dispute but as a collision of paradigms. Pasteur's germ theory holds that specific external microorganisms invade the body and cause specific diseases. Béchamp's terrain theory holds that the internal condition of the host — its chemistry, cellular vitality, and biological environment — is the primary determinant of whether disease manifests. Béchamp went further: he proposed that the body's own cells contain primordial particles he called microzymes, which can change form depending on the terrain.
Pasteur largely won the institutional war. But Béchamp's shadow falls across a great deal of anomalous data that standard germ theory handles awkwardly — including the puzzle of VZV reactivation.
What the Terrain Framework Predicts
If we read the shingles literature through a terrain lens, something interesting happens: the risk factors that virologists catalogue as "triggers of reactivation" look exactly like descriptions of a degraded internal environment. Ageing, chronic stress, co-infection, immunosuppression, epigenetic disruption — these are not exotic external events. They are states of the host. VZV does not reactivate in healthy, unstressed, immunologically robust people except rarely. It reactivates when the terrain shifts. The virus is the same. The host has changed.
The terrain theorist would say: you are not asking the right causal question when you ask "what does VZV do?" You should ask "what is the cell doing, and why is it doing it?"
- VZV is the causative agent. The virus hides in neurons and reactivates when immune surveillance drops.
- Shingles is a viral disease. Treat it with antivirals (acyclovir, valacyclovir) targeting viral replication.
- Prevention means targeting the virus: Shingrix vaccine primes T-cells to recognise VZV antigens.
- The mystery is mechanistic: we don't yet know the exact molecular switch. We will find it.
- The virus is an external entity, even if it integrates deeply into host biology.
- VZV "reactivation" is what happens when the cellular environment can no longer regulate the viral genetic material it has carried for decades.
- Shingles is a disease of the terrain. Restoring immune resilience — through sleep, stress reduction, micronutrients — is the primary intervention.
- Prevention means maintaining immune competence, not merely targeting a specific pathogen.
- The mystery is definitional: if the "virus" only becomes pathological when the host is compromised, is the host the disease and the virus the symptom?
- VLT and ORF63 may be not foreign agents but endogenous regulatory sequences that behave differently in degraded terrain.
The Virus-as-Category Problem
The deeper philosophical challenge is to the category itself. In our earlier investigation of whether viruses "exist" as a distinct biological class, we noted several uncomfortable facts. Viruses are defined by what they lack — they have no metabolism, no ribosomes, no self-replicating machinery. They are described as "obligate intracellular parasites," which is another way of saying they cannot do anything on their own. They exist, in any biologically meaningful sense, only inside cells, using cellular machinery.
This creates a philosophical problem. If a "virus" only becomes active, replicates, and produces the particles we photograph with electron microscopy when it is inside a cell, using the cell's tools, following instructions from its own DNA — is it a distinct organism? Or is it a set of genetic instructions that cells sometimes execute?
VZV and the Boundary Question
VZV raises this in an especially pointed way. During latency, the virus is, by its own biology's admission, not doing anything. No replication. No translation. No particles. The only evidence of its presence is its DNA in the neuronal genome — and a single transcript, VLT, whose function in maintaining latency is still being worked out. If a virus exists only as a stretch of DNA that a cell carries around for decades without expressing it, in what sense is it an invading entity? In what sense is it not simply part of the cell's genetic complement?
The exosome theorists go further: some propose that what we identify as "viral particles" are often cellular vesicles — exosomes — carrying endogenous genetic material, misidentified as foreign. The particles look the same under an electron microscope. The question of whether the genetic sequences are "ours" or "foreign" depends on evolutionary timescales long enough to blur the boundary entirely.
The human genome contains roughly 8% endogenous retroviral sequences — genetic material from ancient viral infections integrated into our germline. These sequences are heritable. Some have been repurposed for biological functions: syncytins, essential for placental development, are derived from retroviral envelope proteins.
VZV is a DNA herpesvirus and does not integrate into the germline the same way. But its ability to persist as episomal DNA in neurons — a circular, stable genetic element maintained across the lifetime — raises the question of where the line between "host" and "pathogen" lies. The virus is in you. It has always been in you, since childhood. It may stay silent forever. At what point does something we carry without harm stop being a pathogen?
These questions are not rhetorical tricks. They point at genuine problems with how virology defines its objects of study — problems that practicing virologists acknowledge in their more philosophical moments, even if they set them aside to do experimental work.
What the Data Cannot Explain Away
It would be intellectually dishonest to present only the heterodox view without acknowledging what it cannot easily account for. The evidence that VZV causes both chickenpox and shingles is about as strong as evidence gets in medicine. When you expose a VZV-naive child to fluid from a shingles blister, they develop chickenpox. When you give immunocompromised people a drug (acyclovir) that specifically blocks VZV DNA polymerase, shingles resolves faster and with less severity. When you vaccinate elderly people with a VZV antigen preparation (Shingrix), shingles incidence drops dramatically. These are not coincidences explicable by terrain effects alone.
The vaccine data in particular is damaging to pure terrain theory. Shingrix works by re-presenting VZV antigens to the immune system, boosting VZV-specific T-cell memory. If shingles were simply a disease of degraded terrain with no specific viral agent, a preparation of VZV proteins should not specifically prevent it. It does.
And yet. The terrain theorist does not need to deny all of this to make a meaningful point. They can accept that VZV is a real genetic entity that really does cause shingles, while still arguing that the causal story is incomplete — that "VZV causes shingles" is like saying "a spark causes a fire." Technically correct. But you also need fuel, oxygen, and the right conditions. The spark does not cause fire in a vacuum or in wet wood. The question is whether medicine spends enough time asking about the oxygen and the wood.
Three Things That Are Probably True Simultaneously
VZV is a real, isolable, sequenceable genetic entity that causes chickenpox and, upon reactivation in neural latency, causes shingles. The viral aetiology is among the most robust in all of medicine.
The molecular trigger for VZV reactivation is not known. A decade of high-quality review papers say so in nearly identical words. The terrain — the host's immune state, stress chemistry, epigenetic landscape — may be the actual operative cause.
The ontological status of a virus — whether it is an organism, a genetic program, or a cellular behaviour — is a live question. VZV's decades-long silent coexistence with its host challenges any simple notion of "foreign invader."
The Ember and the Bellows
The sleeping fire metaphor is apt in more ways than intended. A fire is not simply fuel — it is a relationship between fuel, oxygen, and heat. Take any one away and there is no fire, regardless of what the others are doing. Shingles may be best understood as a relationship: between a genetic entity (VZV) that has coexisted with your neurons since childhood, a nervous system that has carried it silently for decades, and a moment in the host's biology when the conditions for suppression no longer hold.
The conventional virologist focuses on the fuel and works to make it inert — with antivirals that block replication and vaccines that prime the immune defence. This is effective and important. But the terrain question — what changes in the host that allows a decades-dormant sequence to suddenly become pathological — is not just an unanswered mechanistic puzzle. It is the kind of question that could, if answered, change how we think about ageing, stress, epigenetics, and the relationship between the microorganisms (and viral sequences) we carry and the health states we inhabit.
The fact that mainstream science has been unable to identify the molecular trigger for VZV reactivation across a decade of concerted effort suggests it may not be a simple switch waiting to be found. It may be a state transition — an emergent property of a complex system we do not yet have the tools to fully model.
Louis Pasteur is reported to have said, on his deathbed: "Bernard was right. The microbe is nothing. The terrain is everything." The attribution is disputed. But the question it raises is not: how much of what we call infectious disease is truly about the agent, and how much about the body it finds itself in?
For shingles — a disease whose cause is well-established and whose reactivation trigger remains unknown — that question is not academic. It is the next frontier.
